Standout Papers
- Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment (2016)
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II) (2023)
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I) (2023)
Immediate Impact
62 standout
Citing Papers
Atopic dermatitis
2025 Standout
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
Works of Christina Dickson being referenced
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
2023 Standout
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christina Dickson | 658 | 168 | 269 | 225 | 13 | 876 | |
| Joel C. Silverfield | 537 | 124 | 247 | 145 | 13 | 976 | |
| Charles Ludivico | 729 | 226 | 349 | 165 | 13 | 986 | |
| Ying Zhang | 702 | 155 | 350 | 220 | 15 | 1.0k | |
| Christine E. Codding | 601 | 130 | 266 | 174 | 9 | 1.1k | |
| Antonio Sánchez | 666 | 152 | 333 | 101 | 19 | 975 | |
| Jeffrey Neal | 596 | 135 | 312 | 89 | 9 | 840 | |
| Agnes L. Maier | 624 | 214 | 356 | 95 | 22 | 1.1k | |
| Z Domljan | 652 | 104 | 299 | 156 | 18 | 1.1k | |
| Kahaku Emoto | 569 | 187 | 284 | 176 | 9 | 794 | |
| Nasser Khan | 682 | 180 | 334 | 246 | 27 | 953 |
All Works
Loading papers...